Clinical Trials Browser

Phase 3 × Carcinoma, Transitional Cell × lenvatinib × Clear all

NCT03898180 2026-02-05

LEAP-011

Phase 3 Completed

505 enrolled 19 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Transitional Cell